Photodynamic Therapy offers multiple advantages to treat nonmelanoma skin cancer compared to conventional treatment techniques such as surgery, radiotherapy or chemotherapy. Among these advantages are particularly relevant its noninvasive nature, the use of non ionizing radiation and its high selectivity. However the therapeutic efficiency of the current clinical protocol is not complete in all the patients and depends on the type of pathology. Emerging strategies to overcome its current shortcomings include the use of nanostructures that can act as carriers for conventional photosensitizers and improve the treatment selectivity and provide a controlled release of the photoactive agent. In this work, a model for photodynamic therapy combined with gold nanocarriers for a photosensitizer commonly used in dermatology is presented and applied to a basal cell carcinoma in order to predict the cytotoxic agent spatial and temporal evolution.
INTRODUCTION
Photodynamic Therapy (PDT) is an optical treatment modality used in several clinical fields to destroy malignant tissues 1 . It consists of the administration of a photosensitive substance known as photosensitizer which is activated by the subsequent optical irradiation of the tumor area. Thus it is based on a photochemical interaction between three essential components: the photosensitizer, the light and the oxygen. As a consequence reactive oxygen species are produced and destroy the cancerous cells. On the other hand the photosensitizer fluorescence allows to use it as contrast agent for fluorescence based imaging, providing PDT with diagnostic functionality used in several applications such as guided resection, treatment planning and monitoring, outcome treatment assessment or the study of the interactions produced during PDT and the mechanisms involved in cell death 2 .
In dermatology, PDT offers multiple advantages to treat nonmelanoma skin cancer compared to conventional treatment techniques such as surgery, radiotherapy or chemotherapy 3 . Among these advantages are particularly relevant its noninvasive nature, the use of non ionizing radiation and its high selectivity. However the therapeutic efficiency of the current clinical protocol is not complete in all the patients and depends on the type of pathology.
Emerging strategies to overcome the current PDT shortcomings related to the photosensitizer accumulation in the target tissue or the optical radiation distribution include the use of nanostructures with conventional PDT. The future potential ability of nanotechnology to enhance the critical issues of PDT and finally improve its therapeutic effectiveness makes essential to assess dosimetric approaches based on the combined use of PDT and nanoparticles. These last ones can act as carriers for conventional photosensitizers, as excitation energy transducers or active photodynamic elements 4, 5 . Among the former, gold nanoparticles have demonstrated to be excellent carriers for the photosensitizer delivery 6 . As well as being particularly interesting due to their ease of synthesis and chemical modification or their unique optical properties 7 . The use of nanoparticles as delivery vehicle has a great interest to provide an enhanced treatment selectivity in the target tissue and a controlled release of the photoactive agent. The nanoparticles encapsulating the photosensitizer molecules or with the phtosensitizer covalently attached to the nanoparticles surface, make possible to deliver high payloads of photoactive agent, including hydrophobic agents as well as an improved therapeutic selectivity and accumulation in the tumor tissues owing to the enhanced permeability retention (EPR) effects and antibody conjugation.
The future development of customized dosimetry for novel nanoparticle-based PDT requires predictive models able to adjust a great amount of parameters of different nature in order to get an optimal tumor removal 8 . These models must consider the photosensitizer-nanoparticle distribution in the malignant tissue, its influence in the optical radiation distribution and the photochemical reactions underlying PDT in order to get an accurate dosimetric adjustment. Previous studies have theoretically investigated the spatial distribution of nanoparticles by particle trajectory tracking models or its optical and thermal properties, however there is a very limited number of works related to the development of mathematical models that characterize the whole photodynamic process with nanoparticles, which includes not only the photosensitizer-nanoparticle distribution in the malignant tissue but also its influence in the optical radiation distribution and the photochemical reactions evolution. This work is devoted to a predictive model focused on the use of gold nanoparticles as carriers for a photosensitizer commonly used in dermatology. Section 2 describes the model basis and thereafter it is applied to a basal cell carcinoma. The obtained results are presented in Section 3. Finally, the conclusions are listed in the Section 4.
PREDICTIVE MODEL FOR PHOTODYNAMIC THERAPY COMBINED WITH GOLD NANOPARTICLES
The predictive model for nanoparticle-based PDT takes into account the main processes involved in the photodynamic process as well as those effects produced by the administration of gold nanoparticles in the photosensitizer distribution and the optical propagation.
The nanoparticles transport mechanism in the tumor tissue once they leave the bloodstream through the leaky tumor vasculature is obtained by means of a diffusion model considering the vessel walls as the main barrier to the diffusion into the target tissue. The time dependent distribution of the nanoparticles in the tumor tissue is described by Fick's first law of mass flow in equation (1), which is widely employed to model the transport of solutes in tissues. According to this law the diffusion of nanoparticles occurs from areas of high concentration, the vessel walls in this case, to those where the concentration is lower. In this expression j r is the flux vector, T N is the concentration of nanoparticles and D is the diffusivity.
The temporal evolution of the nanoparticles concentration depending on distance from the vessel wall, x , can be calculated as 9 :
where o N is the initial nanoparticles concentration bound to the vessel wall at the beginning of the diffusion time t=0, K is the vessel wall permeability and τ is the particle relaxation time. The photosensitizer concentration at the end of the incubation period is calculated from the nanoparticles distribution profile in the malignant tissue and the photosensitizer payload carried by the nanoparticle.
The optical radiation distribution in the tissue is obtained by means of the Monte Carlo method applied to the Radiation Transport Equation (RTE) 10, 11 , in the expression (3) for a steady-state situation, taking into account the effects of the nanopaticles on the absorption and scattering via Mie Theory 12 . The model assumes that the scattering events are sufficiently numerous as to the light to be considered incoherent, in such a way that polarization or interference effects can be neglected. As a consequence, the basic parameter of light is the specific intensity, ( , ) I r s . The radiation is expected to be at the point r r , and to follow the direction ŝ . The scattering events are treated according to the scattering phase function, ˆ( ') p s s ⋅ , which contains the probabilities of light to be scattered in the different directions. Optical radiation comes from direction ˆ' s and is redirected to ŝ . According to the differential RTE, the radiation from a particle attenuates due to absorption and scattering and also gains power because another particle can scatter light in the direction of the particle of interest 1 . Thus in (3), the absorption and scattering events are taken into account by means of a μ and 
The Monte Carlo method has demonstrated its applicability and accuracy, to solve the radiation transport equation compared with exact solutions. In this work the implementation of the Monte Carlo method applied to the RTT model is the one by Wang and Jacques
10
. The Monte Carlo program assumes that the optical beam is infinitely narrow, and that it has perpendicular incidence. The second assumption is reasonable, but the former can provoke serious disappointments with the reality, particularly if the dimensions of the optical spot and the tissue are of the same order. In order to correct this limitation, another program by the same authors 11 implements the convolution of the results. In this way, the solution of the Monte Carlo analysis can be later transformed for taking into account a cylindrical geometry of the laser beam like the one used in this work. This implementation of the Monte Carlo model is also multi-layered, so it is possible to define several layers of different materials, with their borders always perpendicular to the laser beam, which is very useful in the skin tissues due to they usually can be divided in different strata. Mie's theory permits to calculate the efficiency factors of scattering, Q sca , and extinction, Q ext , for homogeneous spherical nanoparticles with radius r taking into account the complex refractive index of the material m by means of the expressions (4) and (5) respectively. Then the efficiency factor of absorption Q abs can be easily calculated from these last ones as in expression (6).
( )
The amplitude coefficients for the scattered field, n a and n b , are calculated as in the expressions (7) and (8), involving spherical Bessel functions 13 . In these expressions, x kr = is the size parameter, 2 / k π λ = is the wave number, λ is the wavelength in the ambient medium and 1 μ is the ratio of the magnetic permeability of the sphere to the magnetic permeability of the ambient medium. 
Once the photosensitizer accumulation and light distribution are know, the interaction of both elements with the ground state oxygen via a reactions known as Type II triggers a photochemical reaction responsible for singlet oxygen production 14 . This kind of reactive oxygen is considered as the cytotoxic element in charge of killing the carcinogenic cells. Finally the photochemical reactions that take place during PDT can be modeled by means of a differential equations system 15, 16 , (11) 
RESULTS
The structure of the tissue sample employed corresponds to a basal cell carcinoma of 1 mm in depth crossed by a blood vessel whereby the particles are diffused in the tumor located at 0.5 mm from the tumor surface. The diffusion model previously presented allowed us to obtain the time dependent accumulation of nanoparticles bearing the photosensitizer in the tumor tissue once they leave the bloodstream through the leaky tumor vasculature taking into account a vessel permeability of 2.82·10 -7 cm/s and a diffusion coefficient of 6.13·10 -7 cm 2 /s, 9, 17 . The initial concentration of nanoparticles in the vessel wall was fixed to 2·10 19 cm -3 and the diffusion time was 3 h. The photoactive agent concentration at the end of the incubation period was calculated from the nanoparticles distribution profile in the malignant tissue assuming a payload of 32 molecules of photosensitizer per nanoparticle.
The optical absorption and scattering properties of 80 nm gold nanospheres were obtained at the laser wavelength used in PDT (630-635 nm) with the photosensitizer Methyl Aminolevulinate-Protoporphyrin IX (MAL-PpIX). The optical distribution in the multilayer tissue sample was obtained taking into account the tissue optical properties 18, 19 summarized in Table 1 and those of the nanoparticles for a cylindrical optical beam perpendicular to the tissue sample and an irradiance of 100 mW/cm 2 . In this case the tumor tissue layer corresponds to a basal cell carcinoma. Figure 1 shows the efficiency factors of scattering, extinction and absorption obtained by means of Mie's theory for the gold nanoparticles employed. Literature related to well known photosensitizers of the porphyrins family was explored to assign the parameters values related to the photosensitizer PpIX when they were not available 20 . Thus the absorption cross-section of the PpIX molecule at 635 nm was derived from a study 21 of the cellular photosensitizing properties of PpIX carried out in a transformed murine keratinocyte cell line and set to 0.37·10 -15 cm 2 . The relaxation time from singlet excited state to ground state was set to 7.4 ns as reported earlier from fluorescence measurements in cells incubated with 5-aminolevulinic acid induced PpIX 22 . The triplet state lifetime in vivo 23 in skin was set to 26 µs and the relaxation time of singlet oxygen 23 to its ground state to 0.04 µs. Quantum yield transitions between different energetic states were adopted to be similar to those previously considered for the photosensitizer Photofrin ® η10 = 0.2, η 30 = 0.3, η0 = 0.3 and η 13 = 0.8 as well as biomolecular photobleaching, citotoxicity and scavenging rates that were set to 2·10 -10 cm 3 s -1 , 2·10 -9 cm 3 s -1
and 1·10 -9 cm 3 s -1 , respectively 16 . The initial concentration of S1, T and singlet oxygen is 0 cm -3 due to this kind of molecules are not present in the tissue when the optical irradiation period starts. The tissue sample was supposed to be homogeneously oxygenated and without oxygen supply limitations. The initial concentration of cellular oxygen was set to 5·10 17 cm -3 , and diffusion and perfusion rates 16 to 1·10 12 cm -3 s -1
. The initial concentration of intracellular molecular singlet oxygen receptors was 5·10 17 cm -3 , the scavenger concentration was 1·10 3 cm -3 and the cell damage repair rate 16 2.6·10 12 cm -3 s -1 .
The photochemical model was employed to obtain the evolution of the different molecular components involved in the photochemical reactions during the treatment progression. Figure 2 shows the singlet oxygen concentration produced in the tumor tissue as a function of the distance to the tumor surface and to the center of the optical beam as the therapy progresses. Attending to the results, it can be clearly observed a preferential accumulation of singlet oxygen in those zones closer to the nanoparticles supplier vessel. Therefore the therapy effects related to the cytotoxic action of this reactive oxygen would be more pronounced in the tumor areas closer to the nanoparticles supply (i.e. the vessel for systemic administration) and those types of nonmelanoma skin cancers highly vascularized would be more susceptible to suffer singlet oxygen mediated destruction.
Regarding to the temporal singlet oxygen production, Figure 2 presents the singlet oxygen concentration (cm -3 ) as a function of the distance to the tumor surface, z, and the distance to the center of the cylindrical optical beam, r, during the therapy. At 1·10
-24 s, 6 s, 300 s and 600 s in Figure 2 As it can be observed in Fig. 2 a) , singlet oxygen has not yet been produced just when the irradiation starts. However shortly after (Fig. 2 b) ) it reaches a high concentration preferentially in those areas near the vessel walls that will progressively decay faster in those points far from the center of the optical beam. Those tumor areas where the production of singlet oxygen is not enough to destroy the malignant tissue will persist after the therapy. Therefore the results showed could help in a future to choose the proper treatment parameters with the purpose of maximize the cytotoxic agent production and consequently the malignant tissue removal. However these results must be interpreted carefully due to the great amount of parameters of different nature involved in the photodynamic process and the large variability between biological media.
CONCLUSIONS
Despite of the multiple advantages of PDT to treat nonmelanoma skin cancer such as its noninvasive nature, the use of non ionizing radiation or its high selectivity, the therapeutic efficiency of the current clinical protocol is not complete in all the patients and depends on the type of pathology. Emerging strategies to overcome the current PDT shortcomings include the use of nanotechnology combined with conventional PDT. The future potential ability of nanotechnology to enhance the critical issues of PDT and improve its therapeutic effectiveness makes essential to assess dosimetric approaches based on the combined use of PDT and nanoparticles. These last ones can assume different roles in the photodynamic process as carriers for conventional photosensitizers, excitation energy transducers or active photodynamic elements. Gold nanoparticles have unique optical properties, are easy to synthesize and have demonstrated to be excellent carriers for the photosensitizer delivery.
Together with the development of customized dosimetry for novel nanoparticle-based therapeutic strategies, the use of predictive models is essential to optimize the adjustment of the great amount of parameters involved in the final treatment result. A first approach to model the temporal photodynamic response of a basal cell carcinoma using gold nanoparticles as delivery vehicle for a photosensitizer commonly used in dermatology was presented. The distribution of the injected nanocarriers from the vessel wall was characterized by means of Fick´s law which permits to know the spatial photosensitizer accumulation from the vascular supply. The efficiency factors of absorption, scattering and extinction were calculated by means of Mie's theory for homogeneous spherical nanoparticles and the complex refractive index of gold. The propagation of light in the tumor tissue with gold nanoparticles embedded was obtained by a numerical Monte Carlo method. Finally a photochemical model provided the temporal evolution of the molecular components involved in the photodynamic process.
The results provide the temporal and spatial evolution of the cytotoxic agent produced during the photochemical reactions when the photosensitizer is delivered bound to gold nanoparticles injected in the bloodstream. The citotoxic agent produced is crucial to predict the photodynamic treatment response with nanoparticles due to its direct relation with the tumor necrosis. It was observed a preferential accumulation of singlet oxygen in those zones closer to the nanoparticles supplier vessel. Therefore the therapy effects related to the cytotoxic action of this reactive oxygen could be expected to be more pronounced in the tumor areas closer to the nanoparticles supply which indicates that those types of nonmelanoma skin cancers highly vascularized would be more susceptible to suffer singlet oxygen mediated destruction for a systemic administration of nanoparticles. Future works will consider a more complex tumor vasculature which matches closely with the specific characteristics of the target tumor.
